Cargando…

Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study

BACKGROUND: Under the restriction of social activities during the coronavirus disease 2019 (COVID-19) pandemic, there was concern about the loss of muscle mass due to a decrease in physical activity for the elderly. The purpose of this study was to investigate the characteristics of older patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Masaru, Kanayama, Masahiro, Hashimoto, Tomoyuki, Oha, Fumihiro, Shimamura, Yukitoshi, Tsujimoto, Takeru, Hasegawa, Yuichi, Endo, Tsutomu, Nojiri, Hidetoshi, Ishijima, Muneaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394852/
https://www.ncbi.nlm.nih.gov/pubmed/37533001
http://dx.doi.org/10.1186/s12891-023-06755-6
_version_ 1785083462318817280
author Tanaka, Masaru
Kanayama, Masahiro
Hashimoto, Tomoyuki
Oha, Fumihiro
Shimamura, Yukitoshi
Tsujimoto, Takeru
Hasegawa, Yuichi
Endo, Tsutomu
Nojiri, Hidetoshi
Ishijima, Muneaki
author_facet Tanaka, Masaru
Kanayama, Masahiro
Hashimoto, Tomoyuki
Oha, Fumihiro
Shimamura, Yukitoshi
Tsujimoto, Takeru
Hasegawa, Yuichi
Endo, Tsutomu
Nojiri, Hidetoshi
Ishijima, Muneaki
author_sort Tanaka, Masaru
collection PubMed
description BACKGROUND: Under the restriction of social activities during the coronavirus disease 2019 (COVID-19) pandemic, there was concern about the loss of muscle mass due to a decrease in physical activity for the elderly. The purpose of this study was to investigate the characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic in Japan. METHODS: A total of 54 patients with postmenopausal osteoporosis were evaluated in this study. Whole-body dual-energy X-ray absorptiometry was performed pre- and post-COVID-19 pandemic to measure trunk and lower limb muscle mass. At the time of the post-COVID-19 pandemic, we conducted a survey to compare lifestyle before pandemic (the frequency of going out, the frequency of meeting acquaintances or families living apart, regular exercise habits, walking time, family structure), and comorbidities between the muscle mass loss (ML) group and the muscle mass maintenance (MM) group. The ML group consisted of patients with at least a 5% decrease in lower limb muscle mass or trunk muscle mass. RESULTS: A significant difference was found only for the family structure (P = 0.0279); in the ML group, those living alone were the largest group, while in the MM group they were the smallest group. CONCLUSIONS: The ML group was significantly more likely to live alone than the MM group. The current study showed that loss of muscle mass was more common in patients living alone.
format Online
Article
Text
id pubmed-10394852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103948522023-08-03 Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study Tanaka, Masaru Kanayama, Masahiro Hashimoto, Tomoyuki Oha, Fumihiro Shimamura, Yukitoshi Tsujimoto, Takeru Hasegawa, Yuichi Endo, Tsutomu Nojiri, Hidetoshi Ishijima, Muneaki BMC Musculoskelet Disord Research BACKGROUND: Under the restriction of social activities during the coronavirus disease 2019 (COVID-19) pandemic, there was concern about the loss of muscle mass due to a decrease in physical activity for the elderly. The purpose of this study was to investigate the characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic in Japan. METHODS: A total of 54 patients with postmenopausal osteoporosis were evaluated in this study. Whole-body dual-energy X-ray absorptiometry was performed pre- and post-COVID-19 pandemic to measure trunk and lower limb muscle mass. At the time of the post-COVID-19 pandemic, we conducted a survey to compare lifestyle before pandemic (the frequency of going out, the frequency of meeting acquaintances or families living apart, regular exercise habits, walking time, family structure), and comorbidities between the muscle mass loss (ML) group and the muscle mass maintenance (MM) group. The ML group consisted of patients with at least a 5% decrease in lower limb muscle mass or trunk muscle mass. RESULTS: A significant difference was found only for the family structure (P = 0.0279); in the ML group, those living alone were the largest group, while in the MM group they were the smallest group. CONCLUSIONS: The ML group was significantly more likely to live alone than the MM group. The current study showed that loss of muscle mass was more common in patients living alone. BioMed Central 2023-08-02 /pmc/articles/PMC10394852/ /pubmed/37533001 http://dx.doi.org/10.1186/s12891-023-06755-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tanaka, Masaru
Kanayama, Masahiro
Hashimoto, Tomoyuki
Oha, Fumihiro
Shimamura, Yukitoshi
Tsujimoto, Takeru
Hasegawa, Yuichi
Endo, Tsutomu
Nojiri, Hidetoshi
Ishijima, Muneaki
Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study
title Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study
title_full Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study
title_fullStr Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study
title_full_unstemmed Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study
title_short Characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the COVID-19 pandemic – a case–control study
title_sort characteristics of older patients with postmenopausal osteoporosis who developed loss of muscle mass during the covid-19 pandemic – a case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394852/
https://www.ncbi.nlm.nih.gov/pubmed/37533001
http://dx.doi.org/10.1186/s12891-023-06755-6
work_keys_str_mv AT tanakamasaru characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT kanayamamasahiro characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT hashimototomoyuki characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT ohafumihiro characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT shimamurayukitoshi characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT tsujimototakeru characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT hasegawayuichi characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT endotsutomu characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT nojirihidetoshi characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy
AT ishijimamuneaki characteristicsofolderpatientswithpostmenopausalosteoporosiswhodevelopedlossofmusclemassduringthecovid19pandemicacasecontrolstudy